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Background: The environment has an important role in the transmission of healthcare 
associated infections.  This has encouraged interest in novel methods to improve hygiene in 
hospitals.  One such technology is the use of hydrogen peroxide to decontaminate rooms and 
equipment; there are, however, few studies that have investigated the effect of continuous 
dilute hydrogen peroxide (DHP) in the clinical environment. The aim of this study was to 
undertake a feasibility study to assess the use of dilute hydrogen peroxide (DHP) in a critical 
care unit and measure the microbiological impact on surface contamination. 
Methods: We conducted a prospective observational cross-over study in a ten-bed critical 
care unit in one rural Australian hospital. Selected high-touch sites were screened using 
dipslides across three study phases: baseline; continuous DHP; and no DHP (control).  
Quantitative aerobic colony counts (ACC) were assessed against a benchmark standard of 
ACC >2.5cfu/cm2 to indicate hygiene failure.  
Results: There were low levels of microbial contamination in the unit for baseline; DHP; and 
no DHP phases: 2.2% (95% CI 0.7-5.4%) vs 7.7% (95% CI 4.3-13.0%) vs 6% (95% CI 3.2-
10.4%) hygiene failures, respectively. Significant reduction in ACCs did not occur when the 
DHP was operating compared with baseline and control phases.   
Conclusion: Further work is needed to determine whether continuous DHP technology has a 
role in decontamination for healthcare settings. 
Highlights 
• Dilute hydrogen peroxide (DHP) use in a critical care unit 
• No significant effect on levels of viable microbial soil on high-touch surfaces  
• Further research needed to determine role of DHP in a healthcare setting 
Keywords: Infection Control, Health Services, Cross infection, Detergents, Microbiology, 
Environment, Hospitals, Health Facility Environment, Disinfection.
Introduction 
There is evidence to show that the environment plays an important part in the transmission of 
healthcare-associated infection (HAI) (1). Measures to improve environmental cleanliness in 
hospitals are an important component of an infection control program and are currently the 
subject of much research and debate (1–4).  Persistent pathogens pose an ongoing risk of 
transmission between patients (5), since admission to a room previously occupied by a patient 
with a multidrug resistant organism (MRO) is associated with increased risk of acquisition.  
Novel strategies to prevent HAIs are required. 
New equipment aimed at reducing environmental contamination include the use of dilute 
hydrogen peroxide (DHP) technology. This technology utilises ambient air to produce 
hydrogen peroxide as a near-ideal gas, creating concentrations of peroxide that are well 
below human safety thresholds (6). It is an ozone-free process that produces 0.02 ppm of 
hydrogen peroxide gas from oxygen and water vapour in the air.  The action of hydrogen 
peroxide requires direct contact with microorganisms without any specific protein or enzyme 
target.  
DHP has demonstrated in vitro activity against a variety of bacteria, fungi and viruses, but 
there is limited work examining the effects of this technology in the healthcare environment. 
Recent studies have demonstrated the effectiveness of hydrogen peroxide against bacterial 
biofilms (7,8) as well as decontamination of equipment and rooms (9–12).  Many of the 
published studies have used hydrogen peroxide vapour which is different to the continuous 
system being assessed in this study.  Hydrogen peroxide vapour systems require logistical 
planning particularly if a patient room is to be decontaminated. Adequate sealing of doors 
and vents to prevent release of vapour is an important undertaking as hydrogen peroxide 
concentrations are higher compared with continuous DHP technology. This restricts the use 
of a room for a period of time and may affect patient and bed flow in a busy working 
environment. DHP can be used in a facility during routine healthcare in conjunction with 
established cleaning and decontamination practices.   
The aim of this study was to undertake a feasibility study, exploring whether continuous use 
of DHP reduces microbiological contamination of clinical surfaces. Our hypothesis was that 
DHP would reduce the proportion of bed areas and high touch sites demonstrating high levels 
of microbial contamination in a critical care setting. 
Methods 
 
The study was designed as a prospective observational cross-over study based in a 10 bed 
critical care unit (containing both intensive and coronary care beds). The study site is a 160 
bed rural hospital in New South Wales (NSW), Australia.  The unit has used DHP (CIMR™ 
Tech) in the ventilation system for a number of years at a concentration of 0.02ppm hydrogen 
peroxide gas. A level of 1ppm has been assessed as being a permissible level of exposure 
according to the Occupational Safety and Health Administration and International Labour 
Organisation (13,14).  Prior to commencement of the study, hydrogen peroxide was 
undetectable at a 0.1ppm level using the Dräger X-am® 5100 (Dräger) when the DHP unit 
was activated. The primary outcome measure assessed was total aerobic colony count 
(ACC)/cm2 on selected high-touch surfaces in the critical care unit.  
As the study examined the impact of an existing technology on the environment without 
patient level data, there was no requirement for ethical consideration. Institutional approval 
was given for the study.  
Sampling 
Sampling was undertaken by use of TTC Red Spot Medium (Oxoid) dipslides, which have a 
surface area of 10cm2. Cultures were taken from high-touch sites within five randomly 
chosen bed areas once per day for five consecutive days.  Bed areas were defined as the space 
temporarily dedicated to an individual patient for that patient’s stay in the unit (i.e. the patient 
zone). The patient zone accommodates the bed and chair, bedside table, medical devices and 
monitors (15). Eight sites were chosen for sampling in each patient zone and were selected 
based on previous studies (16) and frequently touched sites within the unit (Table 1).   
Sampling of sites were performed by the same investigator who applied dipslides with gentle 
pressure (25g/cm2) to the selected surface for 10 seconds without lateral movement (16,17). 
Dipslides were then sent via courier to the microbiology laboratory on the day of sampling.  
Phases of testing 
Phase 1 testing constituted sampling four weeks after the DHP had been turned off in order to 
establish baseline data.  Phase 2 testing was performed after the DHP had been turned on for 
a period of four weeks. Timing of sampling was undertaken on average 21-23 hours after 
routine cleaning or 6 – 29 hours after a discharge clean. Sites were sampled within bed areas, 
regardless of whether a patient was present or not according to the randomisation strategy.  
Phase 3 testing was performed following cessation of DHP for a period of four weeks prior to 
sampling. The study took place between July 2017 and October 2017. 
Standard cleaning practices 
Cleaning was performed by either  domestic staff or occasionally by nursing staff when 
terminal/discharge cleaning was required. The daily cleaning regimen consisted of: neutral 
detergent wipes for general surfaces and a disinfectant (Viraclean™; major active ingredient 
alkyl dimethyl benzyl ammonium chloride) for patients in isolation. Patients with Clostridium 
difficile had bed spaces cleaned with Chlor-Clean™ (sodium dichloroisocyanurate). Floors 
were cleaned using microfibre mops and hard surface floor cleaner. All medical and most 
other equipment was decontaminated with Viraclean™ or large alcohol wipes between 
patient use and always upon discharge.  
Clinical data  
For each sampling phase background information was collected (Table 2). There were high 
bed occupancy rates for the first two phases and less for phase 3. There were no major 
differences between average staff and visitor numbers across the three study phases.  
Temperature and humidity were averaged across the phases and recorded in the unit using a 




Microbiology testing was performed at NSW Health Pathology Laboratory at John Hunter 
Hospital which is approximately 170km from the rural hospital site. No on-site microbiology 
laboratory was available at the rural hospital and all specimens were transported to the main 
testing laboratory on the day of collection. Dipslides were incubated at 30°C in aerobic 
conditions for 48 hours. Aerobic colony counts were performed manually to obtain 
quantitative counts (cfu/cm2). Counts were classified as no growth; scanty growth (<2.5 
cfu/cm2), light growth (2.5 - 12 cfu/cm2), moderate growth (12 - 40 cfu/cm2), and heavy 
growth (>40  cfu/cm2) (16,17).  Hygiene failures were classed as counts of >2.5 cfu/cm2  
(16,17). Colonies were not identified.  
Statistics 
A sample size of 143 (collected during each of three sampling phases) was calculated with 
power at 80% to detect a difference with 95% confidence and with the following 
assumptions:  Firstly, the mean proportion of hygiene failure (all samples) during the control 
arm (no DHP) would be 22% (proportion with aerobic colony counts (ACC) >2.5 cfu/cm2) 
(16), and secondly, that the mean proportion of hygiene failure (all samples) during the 
intervention arm (using DHP) would be 10% (proportion with ACC >2.5 CFU/cm2). 
Computer generated randomisation was performed to select bed areas for sampling.   
Proportions of sites positive for an organism for each phase of the study was analysed using 
ANOVA.  Total ACC was analysed using regression analysis, taking into account patient 
demographic and clinical data collected. Significance levels of 5% were used for the pre-
specified hypotheses and 95% confidence intervals for the estimated effects.   
Results 
Total aerobic colony counts were assessed according to our protocol’s original hygiene 
failure threshold of >2.5 CFU/cm2.  
Phase 1 – Control phase 
During the control phase, there were only 2.2% (95% CI 0.7-5.4%) failures detected (Figure 
1). When the tap and toilet flush button sites were excluded from analysis a failure rate of 
2.0% (95% CI 0.5-5.5%) was observed. It was decided to adjust the failure threshold to >1 
cfu/cm2 in order to better determine any significant differences between phases. The adjusted 
failure rate was 3.4% (95% CI 1.3-7.0%) using the new benchmark; and 2.7% (95% CI 0.9-
6.4%) when tap and toilet sites were excluded (since they were not in the near patient area).  
Phase 2 – Intervention 
In the intervention phase with DHP, the observed failure rate was 7.7% (95% CI 4.3-13.0%) 
and 8.7% (95% CI 4.8-14.5%) with tap and toilets excluded using the 2.5 cfu/cm2 threshold. 
The failure rates increased when the lower threshold was used (>1 cfu/cm2) to 11.5% (95% 
CI 6.0-15.7%); this increased to 13.4% (95%CI 8.4-20.4%) with tap and toilet site excluded. 
It was noted that whichever failure threshold was utilised, the observed failure rates were 
higher than that of the control phase.  
Phase 3 – Control phase 
A repeat of the control phase with cessation of DHP demonstrated a failure rate of 6% (95% 
CI 3.2-10.4%); and 3.4% (95% CI 1.2-7.4%) with tap and toilet button excluded using the 2.5 
cfu/cm2 threshold. Failure rates increased with the >1 cfu/cm2 threshold to 10.3% (95% CI 
6.4-15.8%); and 8.1% (95% CI 4.3-14.2%) with the tap and toilet buttons excluded. Failure 
rates were lower compared with the intervention phase and higher when compared with phase 
1.  
The pre- and post-effect of DHP was analysed by pooling results for the two control phases 
(1 and 3) and comparing this to the intervention phase 2. Using a failure cut off of >2.5 cfu 
there was a 4.1% failure rate in the absence of DHP compared with a failure rate of 7.7% 
when DHP was used. This was obviously unexpected, given the hypothesis that presence of 
DHP would result in lower levels of contamination. Overall, there was a low level 
background rate of contamination so that implementation of DHP did not result in significant 
reduction in hygiene failures. However, this is difficult to assess given the already low failure 
rates at baseline.  
Discussion 
The results from our feasibility study did not demonstrate a statistically significant effect of 
DHP on reducing surface contamination within a critical care unit in a rural hospital.  
There are a number of confounding factors that could have affected the baseline 
contamination rates of surfaces. Firstly, the study period occurred during winter and spring 
months, during which cases of severe influenza A infections were particularly prevalent. This 
could have altered cleaning practices and behaviour, as there would have been heightened 
infection control practices. Whilst formal episodes of cleaning by cleaning staff were 
documented, it was at the discretion of nursing staff to initiate cleaning of surfaces where 
appropriate. This was not a blinded study and therefore staff in the unit knew when the DHP 
would, and would not, have been in use.  Furthermore, randomly selected bed spaces meant 
that some unoccupied bed spaces were sampled. While the proportions of occupied and 
unoccupied bed spaces remained similar throughout the study, there is a possibility that 
including unoccupied bed sites would have had an impact on total microbial soil recovered. 
The total number of bed areas sampled remained the same across all phases of the study.  
Similar studies investigating the role of hydrogen peroxide in infection control have used a 
variety of techniques to sample surfaces. This has included pre-moistened swabs and 
dipslides. Our study used dipslides for sampling, which may have affected pick up rate of 
organisms on the surface. This was due to the relative rigidity of the dipslides, i.e. it was 
difficult to manoeuvre the slides on cylindrical surfaces such as a bed rail and IV poles. 
Furthermore, growth may have been affected by the residual effect of detergents and other 
chemical cleaning agents present on sampled surfaces. Recommendations by the CDC 
suggest inactivation of common surface disinfectants when surface sampling is performed to 
mitigate the effect on microbial growth (18).   
Rutala et al 2017 (19) employed a similar strategy of continuous DHP against multidrug 
resistant organisms (MDROs) on a pre-contaminated surface and found that there was no 
statistical difference between DHP intervention and control groups. This is similar to the 
findings reported here. One major difference however, is that the DHP was employed in a 
model room and hallway in front of the room(19). This would not account for the other 
factors such as occupancy rate and staff numbers in the unit at any given time which may 
have affected the efficacy of the hydrogen peroxide. The authors concluded that they were 
unable to generate a sufficient germicidal level with the particular DHP units employed.   
A limitation of our study was that we did not have equipment that could measure the 
extremely low hydrogen peroxide concentrations delivered by the system. Further studies 
should factor in regular actual readings throughout testing to demonstrate hydrogen peroxide 
exposure by the continuous DHP system. Despite negligible levels of hydrogen peroxide 
detected, this would not account for the low levels of hygiene failures in the study, as the 
opposite would have been expected. To account for confounders the notion of using pre-
contaminated surfaces or coupons with microorganisms would have been useful; however, 
given the ethical considerations of introducing potential pathogens into a unit with critical 
care patients this was not a feasible approach. Another limitation of our study surrounds the 
broader issue of microbial sampling of the environment. 
As other studies have demonstrated, hydrogen peroxide has a role in decontamination of 
equipment and surfaces and has been employed in our healthcare institution for room 
decontamination. Further work is needed to determine whether continuous DHP technology 
has a role in infection control within a healthcare setting, as the results from our small study 
showed no significant change to surface contamination. 
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Table 1: Sampling sites selected 
Sampling sites 
1.        Bed rail (right) 5.    Hand basin tap handle 
2.        Bed rail (left) 6.    IV pole 
3.        Over bed table 7.    Monitor button 
4.        Bed end/notes     
            Table 
8.    Shared bathroom toilet     
        Flush button 
 
 
Table 2. Background data  
Clinical information collected Phase 1 Phase 2 Phase 3 
% bed occupancy rate  96% 94% 74% 
Number of staff and visitors present in unit at 
time of sampling 
9.6 8.0 8.2 
Temperature (°C) and humidity (%) 20.5°C/40.6%  21.0°C/38.9%  22.0°C/57.1% 
Information regarding time cleaning was completed and products used were collected but the data did not allow for accurate 
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Phase 1 no H2O2 
 
2.2% .7-5.4% 2.0% .5-5.5%   3.4% 1.3-7.0% 2.7% .9-6.4% 
Phase 2 H2O2 
 
7.7% 4.3-13.0% 8.7% 4.8-14.5   11.5% 6.0-15.7% 13.4% 8.4-20.4 
Phase 3 no H2O2 
 
6.0% 3.2-10.4% 3.4% 1.2-7.4   10.3% 6.4-15.8% 8.1% 4.3-14.2 
*Sampling of hand basin taps and shared bathroom toilet flush buttons were excluded from 
data analysis to compare range of hygiene failures  
 
Figure 1 – Hygiene failures detected during the study phases .  
The points on the graph represent the percentage hygiene failure with the calculated 95% 
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